Complex nanostructures based on oligonucleotide optical switches and nanoparticles for intracellular mRNA sensing and silencing. by Adinolfi, B. et al.
 Procedia Engineering  87 ( 2014 )  751 – 754 
Available online at www.sciencedirect.com
1877-7058 © 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license 
(http://creativecommons.org/licenses/by-nc-nd/3.0/).
Peer-review under responsibility of the scientific committee of Eurosensors 2014
doi: 10.1016/j.proeng.2014.11.645 
ScienceDirect
EUROSENSORS 2014, the XXVIII edition of the conference series 
Complex nanostructures based on oligonucleotide optical switches 
and nanoparticles for intracellular mRNA sensing and silencing 
B. Adinolfia, S. Carpib, A. Giannettia, P. Nierib, M. Pellegrino3, G. Sotgiud, S. Tombellia, 
C. Tronoa, G. Varchid, F. Baldinia* 
aIstituto di Fisica Applicata “Nello Carrara”, Consiglio Nazionale delle Ricerche, Via Madonna del Piano 10, 50019 Sesto Fiorentino (FI), Italy 
bDipartimento di Farmacia, Università di Pisa, Via Bonanno, 6, 56126 Pisa (PI), Italy 
cDipartimento di Ricerca Traslazionale e delle Nuove Tecnologie in Medicina e Chirurgia, Università di Pisa, Via Savi 1, 56126 Pisa (PI), Italy 
dIstituto per la Sintesi Organica e la Fotoreattività, Consiglio Nazionale delle Ricerche, Via P. Gobetti 101, 40129 Bologna (BO), Italy 
Abstract 
The design, implementation and characterization of complex nanostructures for intracellular mRNA monitoring constituted by a 
molecular beacon (MB), covalently immobilized onto polymethylmethacrylate (PMMA) fluorescent nanoparticles (NPs) are 
described. The MB molecule, adsorbed onto the nanoparticle for intracellular delivery, is capable to turn on the fluorescence 
emission of its fluorescent label, upon the interaction with a well-defined target mRNA. The mRNA specific for survivin has 
been chosen as target. A MB for survivin mRNA was characterized in vitro to verify its functionality. The functionality and 
specificity of the MB were also examined in living cells by transfection with a classical lipid agent, Lipofectamine. In addition, 
bear and MB-coated PMMA NPs were tested with adenocarcinomic human alveolar basal epithelial cells (A549) in terms of cell 
vitality and internalization. 
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1. Introduction 
The concept of antisense technology as drugs is immediate: the use of a complementary sequence to the mRNA, 
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following the hybridization rules of Watson and Crick, can inhibit its expression then induce a stop in the transfer of 
the information from the DNA to the protein synthesis [1, 2]. Recently, the antisense technology has been combined 
with nanosensing feature, potentially able to provide real time monitoring of intracellular events [3], merging the 
antisense drug property with the optical switch capability. Oligonucleotide optical switches are suitable molecules 
capable of turning on or modifying their light emission on molecular interaction with well-defined molecular targets. 
The use of an antisense oligonucleotide optical switch, able to generate a fluorescent signal when it hybridizes with 
the target mRNA, may represent an innovative strategy that conjugates the ability of sensing specific mRNA with 
the pharmacological silencing activity preventing the overexpression of proteins associated to pathologic conditions. 
Among these types of antisense oligonucleotide, molecular beacons (MBs) are very promising tools to optically 
monitor their interaction with the target molecule. They are formed by oligonucleotidic sequences labeled at the two 
side ends, with a fluorophore FA on one side and either a quencher Q or a second fluorophore FB on the other side, 
with the sequence properly designed so as to form a hairpin structure (stem-loop) when the complementary sequence 
is not present (Figure 1). In this condition, in the absence of the complementary target, the two labels are only a few 
angstroms separated and the fluorophore FA, if excited when the MB structure is closed, does not exhibit 
fluorescence but transfer the absorbed energy to the second label (fluorescence resonance energy transfer). No 
emitted light - if the second label is a quencher - or fluorescence at a longer wavelength than that one of the FA 
fluorescence - if the second label is a second fluorophore - is observed. In the presence of the target, the MB opens 
and the fluorophore FA is no more so close to the second label as to consent the energy transfer to the second label, 
and fluorescence at its emission wavelength is observed. 
The use of carriers for the intracellular drug delivery or for the transportation of drugs in target cells, difficult to 
get in normal conditions, is a well-known strategy and the use of traditional delivery structures, more or less 
complex, such as liposomes, viruses antibodies, micelles, is the applied strategy [4]. With the advent of new nano-
sized materials, fascinating possibilities in the transport within the cells are appeared. The development of efficient 
methodology for the chemical modification has led to the preparation of functionalized nanoparticles [5, 6] on which 
a large variety of active molecules can be immobilized (e.g. peptides, proteins, oligonucleotidic chains and other 
therapeutic agents). An important aspect is the fact that the modified nanostructures have been shown to be able to 
cross the cellular membranes under well-controlled conditions with suitable mechanisms [7]. 
In the present paper, we describe the design, implementation and characterization of complex nanostructures for 
intracellular survivin mRNA monitoring constituted by a molecular beacon, adsorbed on polymethylmethacrylate 
(PMMA) fluorescent nanoparticles (NPs). The mRNA specific for survivin has been chosen as target, being survivin 
a multifunctional protein that plays a role in cancer development and progression [8] and highly overexpressed in 
cancer cells.  
2. Materials and methods 
PMMA nanoparticles were synthesized at ISOF-CNR by emulsion polymerization and they were constituted by a 
core of PMMA surrounded by a shell bearing cationic quaternary ammonium (498 μmol/g) and –NH2 (208 μmol/g) 
groups. The same nanoparticles were also functionalized, during the synthesis, with fluoresceine.  
The survivin molecular beacon was purchased from IBA (Gottingen, Germany) with the following sequence [9]: 
5’-(ATTO647N)CGACGGAGAAAGGGCTGCCACGXCG(BBQ)-3’ X=C6-dT Thio. The underlined sequence 
 
Fig. 1. Structure of a molecular beacon (MB) and its interaction with the specific target.  
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represents the specific sequence for survivin mRNA. Atto 647N (λabs 644 nm, λem 669 nm) and Blackberry Quencher 
650 (λmax ~ 650 nm, useful absorbance between 550 and 750 nm) were used as fluorophore/quencher pair. The MB 
complementary oligonucleotide (target 5’-CCCCTGCCTGGCAGCCCTTTCTCAAGGACC-3’) and a non-specific 
sequence (random, 5'-ATCGGTGCGCTTGTCG-3') were purchased from MWG Biotech (Milan, Italy). RPMI1640 
was purchased from Invitrogen.  
Fluorescence measurements were carried out in a cuvette using, for excitation, a PicoQuant (LDH-P-C-635B) 
laser diode emitting at 635 nm filtered with a bandpass interference filter (ThorLabs FL635-10) at 635. An optical 
fibre (diameter 200 μm) oriented at 90° with respect to the direction of the excitation beam and with a GRIN lens on 
its tip was used to collect the fluorescent collimated signal and to send it to an Andor Shamrock 303 spectrograph. 
Cell images were obtained by a confocal microscope Biorad RadiancePlus and the Z stack images were analysed 
with ImageJ software with MEDNUC or 3D Volume Viewer plugins.  
3. Results and discussions 
3.1. Molecular beacon in solution  
The molecular beacon targeting survivin mRNA was firstly characterized in solution, by evaluating its capability 
of binding the complementary sequence. A solution of 100 nm of MB in buffer (Tris 10 mM, MgCl2 10 mM, pH 8) 
was exposed to different concentrations of the target from 0 to 1000 nM. Fluorescence measurements were 
conducted after 1, 3 and 5 h of incubation of the MB with the different solutions of target and very little variability 
was observed.  
The calibration curves in Figure 2a shows the correct MB working with the increase of the fluorescence 
following an increase in the target concentration. Moreover, the MBs resulted to be specific for the target since the 
signal in presence of the non-specific sequence (100 nM) was equal to the one with only buffer. 
The functionality and specificity of the MB were also examined in living cells by experiments performed on the 
human melanoma A375 cell line and using human monocytes as negative control. The MB was firstly transfected by 
the classical lipid agent, lipofectamine. Our findings demonstrated a fluorescence increase in the cytoplasm 1 h after 
beginning the transfection without evidence of fluorescence signals in the extracellular environment (Figure 2b). 
Moreover, no fluorescence was observed in transfected cells that did not express survivin (monocytes).  




Fig. 2. (a) calibration plot for the molecular beacon 100 nM with increasing concentrations (1-1000 nM) of the target (λex 635 nm). The 
different curves are related to different incubation times; (b) A375 cells treated for 1 h with 100 nM MB-lipofectamine. 
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3.2. Molecular beacon adsorbed onto nanoparticles in cells 
The effects of different concentrations of PMMA nanoparticles on the adenocarcinomic human alveolar basal 
epithelial cells (A549) viability were analyzed by WST-1 assay, a colorimetric test that evaluates the mitochondrial 
enzymatic activity of the cells as index of cell viability. The results, expressed as % of cell viability vs an untreated 
control, showed a not toxic profile of activity of the PMMA nanoparticles up to 25 μg/mL (data not shown). On the 
basis of these results and in order to guarantee the visualization of suitable fluorescent signals, the concentration 10 
μg/mL was chosen for the localization studies realized by confocal microscopy. In this phase, the experimental 
conditions have been optimized considering to use RPMI1640 supplemented with 10% FBS and a time of exposure 
of 1 h and 30 minutes which was the minimum time of treatment to which it was possible to state with certainty the 
intracellular localization of the nanoparticles.  
MB-adsorbed onto NPs was also tested on the A549 cells in terms of internalization. These experiments provided 
a clear evidence of the subcellular distribution of PMMA NPs in living cells as well as of their ability to promote the 
MB internalization (Figure 4). 
4. Conclusion 
We have shown that oligonucleotide optical switches, together with NPs, can play a fundamental role in 
achieving quantitative information on intracellular events. The conducted analytical characterization has 
demonstrated that they can be used not only as simple on-off elements but also as real sensors. 
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Fig. 4. Fluorescence images by confocal microscope of an A549 cell treated with the MB (100 nM) adsorbed onto PMMA NPs (10 Pg/mL) for 1 
h and 30 minutes. Left: image of the cell with Oex = 488 nm (NPs); right: image of the cell with Oex = 635 nm (MB). 
